We are live on ! Find out more
GMO

General Moly, Inc.
GMO

Delisted

GMO was delisted on the 30th of September, 2020.

66 hedge funds and large institutions have $22.2M invested in General Moly, Inc. in 2014 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $10K | Put options by funds: $6K

50% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 14

16% more capital invested

Capital invested by funds: $19.1M → $22.2M (+$3.04M)

12% more funds holding

Funds holding: 5966 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

50% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 22

Holders
66
Holders Change
+7
Holders Change %
+11.86%
% of All Funds
1.9%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
11
Reduced
22
Closed
14
Calls
$10K
Puts
$6K
Net Calls
+$4K
Net Calls Change
+$4K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$73K +$56.5K +54,156 +585%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$71K +$45.3K +43,441 +241%
SFM
28
Soros Fund Management
New York
$63K +$56.8K +54,400 New
AI
29
ArchPoint Investors
Florida
$48K -$2.09K -2,000 -5%
GC
30
Guggenheim Capital
Illinois
$35K -$1.82K -1,748 -5%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$34K
SG Americas Securities
32
SG Americas Securities
New York
$34K +$31.2K +29,932 New
Millennium Management
33
Millennium Management
New York
$30K +$27.2K +26,100 New
CL
34
CSS LLC
Illinois
$25K
Charles Schwab
35
Charles Schwab
California
$19K -$94.2K -90,300 -85%
BA
36
BlackRock Advisors
Delaware
$19K -$25.2K -24,145 -59%
Barclays
37
Barclays
United Kingdom
$18K +$17.1K +16,348 +725%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$17K +$10.5K +10,100 +253%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$17K +$15.4K +14,800 New
OAM
40
Oxford Asset Management
United Kingdom
$16K -$119K -113,780 -89%
GA
41
Geneva Advisors
Illinois
$16K
Jane Street
42
Jane Street
New York
$15K +$13.7K +13,100 New
Prudential Financial
43
Prudential Financial
New Jersey
$14K +$12.5K +12,000 New
TRCT
44
Tower Research Capital (TRC)
New York
$13K -$13.6K -13,040 -54%
Wells Fargo
45
Wells Fargo
California
$13K +$1.46K +1,400 +14%
BIM
46
BlackRock Investment Management
Delaware
$12K -$192K -184,181 -94%
OC
47
Oppenheimer & Co
New York
$12K
Stifel Financial
48
Stifel Financial
Missouri
$12K +$11.1K +10,670 New
1IC
49
1919 Investment Counsel
Maryland
$6K +$5.22K +5,000 New
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K

GMO Hedge Fund Activity: Q2 2014 in Review

66 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q2 2014, worth a combined $22.2M — up 16% from $19.1M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new GMO positions and 14 closed out — a net gain of 7 holders — while 11 added to existing stakes and 22 trimmed.

The largest buyer was University of Texas/Texas AM Investment Management Co (UTIMCO), opening a new position worth an estimated $3.05M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.48M.

  • 66 institutional investors held General Moly, Inc. (GMO) as of Q2 2014, up from 59 in Q1 2014.
  • Funds reported $22.2M of General Moly, Inc. stock for Q2 2014, up 16% quarter-over-quarter.
  • 21 funds opened new General Moly, Inc. positions in Q2 2014 and 14 closed out, a net change of +7 holders.
  • The largest General Moly, Inc. buyer in Q2 2014 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $3.05M added.
  • The largest General Moly, Inc. seller in Q2 2014 was BlackRock Fund Advisors, an estimated $1.48M sold.

Based on aggregated 13F filings for Q2 2014.